AbdAlla S, El Hakim A, Abdelbaset A, Elfaramawy Y, Quitterer U (2015) Inhibition of ACE retards tau hyperphosphorylation and signs of neuronal degeneration in aged rats subjected to chronic mild stress. BioMed Res Int 2015:917156. https://doi.org/10.1155/2015/917156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abiodun OA, Ola MS (2020) Role of brain renin angiotensin system in neurodegeneration: An update. Saudi J Biol Sci 27(3):905–912. https://doi.org/10.1016/j.sjbs.2020.01.026

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvarez A, Cerdá-Nicolás M, Naim Abu Nabah Y, Mata M, Issekutz AC, Panés J, Lobb RR, Sanz M-JJB (2004) Direct evidence of leukocyte adhesion in arterioles by angiotensin II. J Blood 104(2):402–408. https://doi.org/10.1182/blood-2003-08-2974

Article  CAS  Google Scholar 

Arregui A, Perry EK, Rossor M, Tomlinson BE (1982) Angiotensin converting enzyme in Alzheimer’s disease increased activity in caudate nucleus and cortical areas. J Neurochem 38(5):1490–1492. https://doi.org/10.1111/j.1471-4159.1982.tb07930.x

Article  CAS  PubMed  Google Scholar 

Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377(9770):1019–1031. https://doi.org/10.1016/S0140-6736(10)61349-9

Article  PubMed  Google Scholar 

Bartolome F, Carro E, Alquezar C (2022) Oxidative stress in tauopathies: From cause to therapy. Antioxidants (Basel) 11(8):1421. https://doi.org/10.3390/antiox11081421

Article  CAS  PubMed  Google Scholar 

Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, Leng Y, Chuang DM, Saavedra JM (2011) Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 36(4):857–870. https://doi.org/10.1038/npp.2010.225

Article  CAS  PubMed  Google Scholar 

Benigni A, Cassis P, Remuzzi G (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2(7):247–257. https://doi.org/10.1002/emmm.201000080

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernstein KE, Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Lopes DH, Shah KH, Bernstein EA, Fuchs DT, Yu JJ, Pham M, Black KL, Shen XZ, Fuchs S, Koronyo-Hamaoui M (2014) Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer’s-like cognitive decline. J Clin Invest 124(3):1000–1012. https://doi.org/10.1172/JCI66541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE (2014) Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63(3):572–579. https://doi.org/10.1161/HYPERTENSIONAHA.113.01743

Article  CAS  PubMed  Google Scholar 

Brosnihan KB, Senanayake PS, Li P, Ferrario CM (1999) Bi-directional actions of estrogen on the renin-angiotensin system. Braz J Med Biol Res 32(4):373–381. https://doi.org/10.1590/s0100-879x1999000400001

Article  CAS  PubMed  Google Scholar 

Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimers Dement 12(6):719–732. https://doi.org/10.1016/j.jalz.2016.02.010

Article  PubMed  Google Scholar 

Capettini LS, Montecucco F, Mach F, Stergiopulos N, Santos RA, da Silva RF (2012) Role of renin-angiotensin system in inflammation, immunity and aging. Curr Pharm des 18(7):963–970. https://doi.org/10.2174/138161212799436593

Article  CAS  PubMed  Google Scholar 

Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165. https://doi.org/10.1186/s12974-023-02853-3

Article  PubMed  PubMed Central  Google Scholar 

Cuddy LK, Prokopenko D, Cunningham EP, Brimberry R, Song P, Kirchner R, Chapman BA, Hofmann O, Hide W, Procissi D, Hanania T, Leiser SC, Tanzi RE, Vassar R (2020) Abeta-accelerated neurodegeneration caused by Alzheimer's-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice. Sci Transl Med 12(563) https://doi.org/10.1126/scitranslmed.aaz2541

Cummings JL (2004) Alzheimer’s disease. N Engl J Med 351(1):56–67. https://doi.org/10.1056/NEJMra040223

Article  CAS  PubMed  Google Scholar 

Ding J, Yu M, Jiang J, Luo Y, Zhang Q, Wang S, Yang F, Wang A, Wang L, Zhuang M, Wu S, Zhang Q, Xia Y, Lu D (2020) Angiotensin II decreases endothelial nitric oxide synthase phosphorylation via AT(1)R Nox/ROS/PP2A pathway. Front Physiol 11:566410. https://doi.org/10.3389/fphys.2020.566410

Article  PubMed  PubMed Central  Google Scholar 

Elkins JS, Douglas VC, Johnston SC (2004) Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology 62(3):363–368. https://doi.org/10.1212/01.wnl.0000106823.72493.ff

Article  CAS  PubMed  Google Scholar 

Fakhoury M (2018) Microglia and astrocytes in alzheimer’s disease: Implications for therapy. Curr Neuropharmacol 16(5):508–518. https://doi.org/10.2174/1570159X15666170720095240

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. https://doi.org/10.1016/0022-3956(75)90026-6

Article  CAS  PubMed  Google Scholar 

Gebre AK, Altaye BM, Atey TM, Tuem KB, Berhe DF (2018) Targeting renin-angiotensin system against alzheimer’s disease. Front Pharmacol 9:440. https://doi.org/10.3389/fphar.2018.00440

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goel R, Bhat SA, Rajasekar N, Hanif K, Nath C, Shukla R (2015) Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition. Pharmacol Biochem Behav 133:132–145. https://doi.org/10.1016/j.pbb.2015.04.002

Article  CAS  PubMed  Google Scholar 

Gouveia F, Camins A, Ettcheto M, Bicker J, Falcao A, Cruz MT, Fortuna A (2022) Targeting brain renin-angiotensin system for the prevention and treatment of Alzheimer’s disease: Past, present and future. Ageing Res Rev 77:101612. https://doi.org/10.1016/j.arr.2022.101612

Article  CAS  PubMed  Google Scholar 

Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356. https://doi.org/10.1126/science.1072994

Article  CAS  PubMed  Google Scholar 

Hemming ML, Selkoe DJ (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280(45):37644–37650. https://doi.org/10.1074/jbc.M508460200

Article  CAS  PubMed  Google Scholar 

Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276(51):47863–47868. https://doi.org/10.1074/jbc.M104068200

Article  CAS  PubMed  Google Scholar 

Hu H, Meng L, Bi YL, Zhang W, Xu W, Shen XN, Ou YN, Ma YH, Dong Q, Tan L, Yu JT (2022) Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: The CABLE study. Alzheimers Dement 18(1):53–64. https://doi.org/10.1002/alz.12377

Article  CAS  PubMed  Google Scholar 

Jack CR, Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 14(4):535-562 https://doi.org/10.1016/j.jalz.2018.02.018

Jochemsen HM, Teunissen CE, Ashby EL, van der Flier WM, Jones RE, Geerlings MI, Scheltens P, Kehoe PG, Muller M (2014) The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease. Alzheimers Res Ther 6(3):27. https://doi.org/10.1186/alzrt257